Hirai A, Kino T, Tokinaga K, Tahara K, Tamura Y, Yoshida S
Second Department of Internal Medicine, Chiba University Medical School, Japan.
J Clin Invest. 1994 Dec;94(6):2215-23. doi: 10.1172/JCI117583.
Sterol carrier protein 2 (SCP2) has been shown to be involved in intracellular transport and metabolism of cholesterol. However, there have been no reports concerning SCP2 in macrophages, the major source of atheromatous foam cells. We investigated whether SCP2 is present in rat peritoneal macrophages and determined the changes of SCP2 and its mRNA levels in macrophages during form cell formation induced by acetylated LDL (AcLDL). Immunoblot analysis and Northern blot analysis demonstrated that both SCP2 and its mRNA are expressed in rat peritoneal macrophages. Incubations with AcLDL caused a dose- and time-dependent increase of cellular esterified cholesterol, SCP2 and its mRNA in rat peritoneal macrophages. The inhibitor of acyl-CoA:cholesterol acyltransferase further enhanced AcLDL-induced increase of SCP2 protein and its mRNA. Incubations with 25-hydroxy cholesterol also caused a dose-dependent stimulation of SCP2 gene expression in macrophages, while incubation with maleylated BSA had no effect. These results suggest that the increment of cellular-free cholesterol is responsible for enhanced SCP2 gene expression in macrophages. The enhancement of SCP2 gene expression by AcLDL suggests that SCP2 may play an important role during foam cell formation induced by AcLDL which may be most important step for the atherosclerosis.
固醇载体蛋白2(SCP2)已被证明参与胆固醇的细胞内运输和代谢。然而,关于巨噬细胞(动脉粥样硬化泡沫细胞的主要来源)中SCP2的报道尚无。我们研究了SCP2是否存在于大鼠腹膜巨噬细胞中,并确定了在乙酰化低密度脂蛋白(AcLDL)诱导的泡沫细胞形成过程中巨噬细胞中SCP2及其mRNA水平的变化。免疫印迹分析和Northern印迹分析表明,SCP2及其mRNA在大鼠腹膜巨噬细胞中均有表达。用AcLDL孵育导致大鼠腹膜巨噬细胞中细胞酯化胆固醇、SCP2及其mRNA呈剂量和时间依赖性增加。酰基辅酶A:胆固醇酰基转移酶抑制剂进一步增强了AcLDL诱导的SCP2蛋白及其mRNA的增加。用25-羟基胆固醇孵育也导致巨噬细胞中SCP2基因表达呈剂量依赖性刺激,而用马来酰化牛血清白蛋白孵育则无影响。这些结果表明,细胞游离胆固醇的增加是巨噬细胞中SCP2基因表达增强的原因。AcLDL对SCP2基因表达的增强表明,SCP2可能在AcLDL诱导的泡沫细胞形成过程中起重要作用,而这可能是动脉粥样硬化最重要的步骤。